S&P 500
6,005.88
+0.1%
+$5.52
DJI
42,761.76
-0.0%
-$1.11
NASDAQ
19,591.24
+0.3%
+$61.28
Bitcoin
109,637.00
+3.9%
+4,147.22
AAPL
$201.70
-1.1%
-$2.22
AMZN
$217.31
+1.8%
+$3.74
GOOG
$177.80
+1.8%
+$3.09
META
$694.90
-0.4%
-$2.81
MSFT
$472.66
+0.5%
+$2.28
NVDA
$142.74
+0.7%
+$1.02
TSLA
$308.41
+4.5%
+$13.27
Check-Cap (NASDAQ: CHEK)
$0.80
(-0.2%)
-$0.00
Price as of June 9, 2025, 2:54 p.m. ET
Check-Cap Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Check-Cap Company Info
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.